Skip to main content
. 2021 Sep 23;12:748566. doi: 10.3389/fimmu.2021.748566

Table 2.

Relative abundance (%) of the main IgG glycome features in COVID-19 patients and the healthy controls.

Summary glycans COVID-19 patients (n = 104) Controls (n = 104) Z P
Fucosylation 82.54 (72.36–87.21) 95.64 (94.12–96.69) 10.874 <0.001
Bisecting GlcNAc 14.30 (12.57–15.66) 15.39 (13.48–17.08) 2.398 0.016
Galactosylation 76.13 (67.14–83.02) 69.21 (63.41–72.93) 4.668 <0.001
Sialylation 29.68 (21.75–39.29) 20.60 (17.48–23.82) 6.296 <0.001

GlcNAc, N-acetylglucosamine.